|
1
|
Asakura K, Nishiwaki Y, Inoue N, Hibi T,
Watanabe M and Takebayashi T: Prevalence of ulcerative colitis and
Crohn's disease in Japan. J Gastroenterol. 44:659–665. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xavier RJ and Podolsky DK: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brazil JC, Louis NA and Parkos CA: The
role of polymorpho-nuclear leukocyte trafficking in the
perpetuation of inflammation during inflammatory bowel disease.
Inflamm Bowel Dis. 19:1556–1565. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kanmura S, Uto H, Numata M, Hashimoto S,
Moriuchi A, Fujita H, Oketani M, Ido A, Kodama M, Ohi H and
Tsubouchi H: Human neutrophil peptides 1–3 are useful biomarkers in
patients with active ulcerative colitis. Inflamm Bowel Dis.
15:909–917. 2009. View Article : Google Scholar
|
|
5
|
Hashimoto S, Uto H, Kanmura S, Sakiyama T,
Oku M, Iwashita Y, Ibusuki R, Sasaki F, Ibusuki K, Takami Y,
Moriuchi A, Oketani M, Ido A and Tsubouchi H: Human neutrophil
peptide-1 aggravates dextran sulfate sodium-induced colitis.
Inflamm Bowel Dis. 18:667–675. 2012. View Article : Google Scholar
|
|
6
|
Territo MC, Ganz T, Selsted ME and Lehrer
R: Monocyte-chemotactic activity of defensins from human
neutrophils. J Clin Invest. 84:2017–2020. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chertov O, Michiel DF, Xu L, Wang JM, Tani
K, Murphy WJ, Longo DL, Taub DD and Oppenheim JJ: Identification of
defensin-1, defensin-2, and CAP37/azurocidin as T-cell
chemoattractant proteins released from interleukin-8-stimulated
neutrophils. J Biol Chem. 271:2935–2940. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang D, Chen Q, Chertov O and Oppenheim
JJ: Human neutrophil defensins selectively chemoattract naive T and
immature dendritic cells. J Leukoc Biol. 68:9–14. 2000.PubMed/NCBI
|
|
9
|
van Wetering S, Mannesse-Lazeroms SP, van
Sterkenburg MA and Hiemstra PS: Neutrophil defensins stimulate the
release of cytokines by airway epithelial cells: modulation by
dexamethasone. Inflamm Res. 51:8–15. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khine AA, Del Sorbo L, Vaschetto R, Voglis
S, Tullis E, Slutsky AS, Downey GP and Zhang H: Human neutrophil
peptides induce interleukin-8 production through the
P2Y6 signaling pathway. Blood. 107:2936–2942. 2006.
View Article : Google Scholar
|
|
11
|
Sakamoto N, Mukae H, Fujii T, Ishii H,
Yoshioka S, Kakugawa T, Sugiyama K, Mizuta Y, Kadota J, Nakazato M
and Kohno S: Differential effects of alpha- and beta-defensin on
cytokine production by cultured human bronchial epithelial cells.
Am J Physiol Lung Cell Mol Physiol. 288:L508–L513. 2005. View Article : Google Scholar
|
|
12
|
Liu CY, Lin HC, Yu CT, Lin SM, Lee KY,
Chen HC, Chou CL, Huang CD, Chou PC, Liu WT, Wang CH and Kuo HP:
The concentration-dependent chemokine release and pro-apoptotic
effects of neutrophil-derived alpha-defensin-1 on human bronchial
and alveolar epithelial cells. Life Sci. 80:749–758. 2007.
View Article : Google Scholar
|
|
13
|
Syeda F, Liu HY, Tullis E, Liu M, Slutsky
AS and Zhang H: Differential signaling mechanisms of HNP-induced
IL-8 production in human lung epithelial cells and monocytes. J
Cell Physiol. 214:820–827. 2008. View Article : Google Scholar
|
|
14
|
Amenomori M, Mukae H, Ishimatsu Y,
Sakamoto N, Kakugawa T, Hara A, Hara S, Fujita H, Ishimoto H,
Hayashi T and Kohno S: Differential effects of human neutrophil
peptide-1 on growth factor and interleukin-8 production by human
lung fibroblasts and epithelial cells. Exp Lung Res. 36:411–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Zhu HY and Beuerman RW: Stimulation
of specific cytokines in human conjunctival epithelial cells by
defensins HNP1, HBD2, and HBD3. Invest Ophthalmol Vis Sci.
50:644–653. 2009. View Article : Google Scholar
|
|
16
|
Ahn JK, Huang B, Bae EK, Park EJ, Hwang
JW, Lee J, Koh EM and Cha HS: The role of α-defensin-1 and related
signal transduction mechanisms in the production of IL-6, IL-8 and
MMPs in rheumatoid fibroblast-like synoviocytes. Rheumatology
(Oxford). 52:1368–1376. 2013. View Article : Google Scholar
|
|
17
|
Koch AE, Polverini PJ, Kunkel SL, Harlow
LA, DiPietro LA, Elner VM, Elner SG and Strieter RM: Interleukin-8
as a macrophage-derived mediator of angiogenesis. Science.
258:1798–1801. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mitsuyama K, Toyonaga A, Sasaki E,
Watanabe K, Tateishi H, Nishiyama T, Saiki T, Ikeda H, Tsuruta O
and Tanikawa K: IL-8 as an important chemoattractant for
neutrophils in ulcerative colitis and Crohn’s disease. Clin Exp
Immunol. 96:432–436. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mazzucchelli L, Hauser C, Zgraggen K,
Wagner H, Hess M, Laissue JA and Mueller C: Expression of
interleukin-8 gene in inflammatory bowel disease is related to the
histological grade of active inflammation. Am J Pathol.
144:997–1007. 1994.PubMed/NCBI
|
|
20
|
Rodríguez-Perálvarez ML, García-Sánchez V,
Villar-Pastor CM, González R, Iglesias-Flores E, Muntane J and
Gómez-Camacho F: Role of serum cytokine profile in ulcerative
colitis assessment. Inflamm Bowel Dis. 18:1864–1871. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kolachala VL, Bajaj R, Chalasani M and
Sitaraman SV: Purinergic receptors in gastrointestinal
inflammation. Am J Physiol Gastrointest Liver Physiol.
294:G401–G410. 2008. View Article : Google Scholar
|
|
22
|
McAlroy HL, Ahmed S, Day SM, Baines DL,
Wong HY, Yip CY, Ko WH, Wilson SM and Collett A: Multiple P2Y
receptor subtypes in the apical membranes of polarized epithelial
cells. Br J Pharmacol. 131:1651–1658. 2000. View Article : Google Scholar
|
|
23
|
Coutinho-Silva R, Stahl L, Cheung KK, de
Campos NE, de Oliveira Souza C, Ojcius DM and Burnstock G: P2X and
P2Y purinergic receptors on human intestinal epithelial carcinoma
cells: effects of extracellular nucleotides on apoptosis and cell
proliferation. Am J Physiol Gastrointest Liver Physiol.
288:G1024–G1035. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bahrami F, Kukulski F, Lecka J, Tremblay
A, Pelletier J, Rockenbach L and Sévigny J: Purine-metabolizing
ectoenzymes control IL-8 production in human colon HT-29 cells.
Mediators Inflamm. 2014:8798952014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kruse R, Säve S and Persson K: Adenosine
triphosphate induced P2Y2 receptor activation induces
proinflammatory cytokine release in uroepithelial cells. J Urol.
188:2419–2425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mortaz E, Henricks PA, Kraneveld AD, Givi
ME, Garssen J and Folkerts G: Cigarette smoke induces the release
of CXCL-8 from human bronchial epithelial cells via TLRs and
induction of the inflammasome. Biochim Biophys Acta.
1812:1104–1110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nylund G, Nordgren S and Delbro DS:
Expression of P2Y2 purinoceptors in MCG 101 murine
sarcoma cells, and HT-29 human colon carcinoma cells. Auton
Neurosci. 112:69–79. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Otte JM, Zdebik AE, Brand S, Chromik AM,
Strauss S, Schmitz F, Steinstraesser L and Schmidt WE: Effects of
the cathelicidin LL-37 on intestinal epithelial barrier integrity.
Regul Pept. 156:104–117. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Grbic DM, Degagné E, Langlois C, Dupuis AA
and Gendron FP: Intestinal inflammation increases the expression of
the P2Y6 receptor on epithelial cells and the release of
CXC chemokine ligand 8 by UDP. J Immunol. 180:2659–2668. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Somers GR, Hammet FM, Trute L, Southey MC
and Venter DJ: Expression of the P2Y6 purinergic
receptor in human T cells infiltrating inflammatory bowel disease.
Lab Invest. 78:1375–1383. 1998.PubMed/NCBI
|
|
31
|
Köttgen M, Löffler T, Jacobi C, Nitschke
R, Pavenstädt H, Schreiber R, Frische S, Nielsen S and Leipziger J:
P2Y6 receptor mediates colonic NaCl secretion via
differential activation of cAMP-mediated transport. J Clin Invest.
111:371–379. 2003. View Article : Google Scholar
|
|
32
|
Delbro DS, Nylund G and Nordgren S:
Demonstration of P2Y4 purinergic receptors in the HT-29
human colon cancer cell line. Auton Autacoid Pharmacol. 25:163–166.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Communi D, Robaye B and Boeynaems JM:
Pharmacological characterization of the human P2Y11
receptor. Br J Pharmacol. 128:1199–1206. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hoffmann E, Dittrich-Breiholz O, Holtmann
H and Kracht M: Multiple control of interleukin-8 gene expression.
J Leukoc Biol. 72:847–855. 2002.PubMed/NCBI
|
|
35
|
Jijon HB, Panenka WJ, Madsen KL and
Parsons HG: MAP kinases contribute to IL-8 secretion by intestinal
epithelial cells via a posttranscriptional mechanism. Am J Physiol
Cell Physiol. 283:C31–C41. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Waetzig GH and Schreiber S: Review
article: mitogen-activated protein kinases in chronic intestinal
inflammation - targeting ancient pathways to treat modern diseases.
Aliment Pharmacol Ther. 18:17–32. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kaiser GC, Yan F and Polk DB: Mesalamine
blocks tumor necrosis factor growth inhibition and nuclear factor
kappaB activation in mouse colonocytes. Gastroenterology.
116:602–609. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Khare V, Lyakhovich A, Dammann K, Lang M,
Borgmann M, Tichy B, Pospisilova S, Luciani G, Campregher C,
Evstatiev R, Pflueger M, Hundsberger H and Gasche C: Mesalamine
modulates intercellular adhesion through inhibition of p-21
activated kinase-1. Biochem Pharmacol. 85:234–244. 2013. View Article : Google Scholar :
|
|
39
|
Subramanian S, Rhodes JM, Hart CA, Tam B,
Roberts CL, Smith SL, Corkill JE, Winstanley C, Virji M and
Campbell BJ: Characterization of epithelial IL-8 response to
inflammatory bowel disease mucosal E. coli and its inhibition by
mesalamine. Inflamm Bowel Dis. 14:162–175. 2008. View Article : Google Scholar
|
